In vivo imaging studies demonstrated that Fv-LDP-D3 could selectively accumulate at tumor sites in the KYSE520 xenograft model where it was retained for a long period of time, suggesting that the properties of human serum albumin may prolong the half-life of drugs. This evidence concerns the gene ALB and neoplasm.